Read Trending Stories
- » Late Radar: BlackRock Ups CHK Stake, VeriFone Crashes 9%
- » Is Facebook Competing With Itself With Photo-Sharing App?
- » Media Titans Making Waves: Sirius XM, Netflix, News Corp, Viacom
- » Healthcare Biz Recap: Rosetta Genomics Spikes, Dynasil Pops, J&J Ticks Up
- » Energy Biz Review: Chesapeake Energy's Reports, CVR Energy Icahn Drama
Today's Trending Stocks
Click a Company to Research Now:
- Bank of America (BAC)
- Apple . (AAPL)
- Facebook (FB)
- AT&T (T)
- Nokia (NOK)
- Tiffany & Co. (TIF)
- Signet Jewelers Ltd. (SIG)
- NetApp . (NTAP)
Insiders are generally long-term investors due to restriction in making short-term profits. In contrast, wealth management institutions always have short-term investment. Wall St. Watchdog reveals information regarding the insiders and institutions which recently increased stock shares of Medtronic, Inc. (NYSE:MDT).
SEC data indicate these insiders have bought Medtronic, Inc.’s stock since 06/30/2011:
Schuler Jack W: act as Director. On 09/01/2011, bought 10,000 shares, worth $351,400.
Anderson Richard H: act as Director. On 08/31/2011, bought 3,000 shares, worth $105,700.
Powell Kendall J: act as Director. On 09/01/2011, bought 3,000 shares, worth $105,600.
SEC data indicate that these institutions significantly increased their stock shares of Medtronic, Inc. in Q3 2011:
MORGAN STANLEY: On 06/30/2011, held 0 shares. On 09/30/2011, held 4,686,932 shares, worth $154,621,887.
RCM CAPITAL MANAGEMENT LLC: On 06/30/2011, held 0 shares. On 09/30/2011, held 3,130,630 shares, worth $103,279,484.
PAULSON MANAGEMENT LLC: On 06/30/2011, held 0 shares. On 09/30/2011, held 1,960,300 shares, worth $64,670,297.
WATERSTONE CAPITAL MANAGEMENT, L.P.: On 06/30/2011, held 0 shares. On 09/30/2011, held 949,990 shares, worth $31,340,170.
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO: On 06/30/2011, held 0 shares. On 09/30/2011, held 804,539 shares, worth $26,541,742.
About the company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
Competitors to Watch: Boston Scientific Corp. (NYSE:BSX), St. Jude Medical, Inc. (NYSE:STJ), Edwards Lifesciences Corp (NYSE:EW), Johnson & Johnson (NYSE:JNJ), ZOLL Medical Corporation (NASDAQ:ZOLL), Abbott Laboratories (NYSE:ABT), Stryker Corporation (NYSE:SYK), Integra LifeSciences Hldgs. Corp. (NASDAQ:IART), Intuitive Surgical (NASDAQ:ISRG), CONMED Corporation (NASDAQ:CNMD), and Greatbatch Inc. (NYSE:GB).
(Note: Data regarding Medtronic, Inc.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)
Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>
Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>
Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!


